0000919574-26-002900.txt : 20260512 0000919574-26-002900.hdr.sgml : 20260512 20260512182438 ACCESSION NUMBER: 0000919574-26-002900 CONFORMED SUBMISSION TYPE: SCHEDULE 13G/A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20260512 DATE AS OF CHANGE: 20260512 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Erasca, Inc. CENTRAL INDEX KEY: 0001761918 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 831217027 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-92728 FILM NUMBER: 26970236 BUSINESS ADDRESS: STREET 1: 3115 MERRYFIELD ROW STREET 2: THIRD FLOOR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 465-6511 MAIL ADDRESS: STREET 1: 3115 MERRYFIELD ROW STREET 2: THIRD FLOOR CITY: SAN DIEGO STATE: CA ZIP: 92121 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SUVRETTA CAPITAL MANAGEMENT, LLC CENTRAL INDEX KEY: 0001569064 ORGANIZATION NAME: EIN: 453704500 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G/A BUSINESS ADDRESS: STREET 1: 540 MADISON AVENUE STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2127025204 MAIL ADDRESS: STREET 1: 540 MADISON AVENUE STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0000919574-25-004725 0001569064 XXXXXXXX LIVE 1 Common Stock, $0.0001 par value per share 03/31/2026 0001761918 Erasca, Inc. 29479A108 3115 Merryfield Row, Suite 300 San Diego CA 92121 Rule 13d-1(b) Suvretta Capital Management, LLC b DE 0.00 3434967.00 0.00 3434967.00 3434967.00 N 1.1 IA OO Averill Master Fund, Ltd. b E9 0.00 2945497.00 0.00 2945497.00 2945497.00 N 0.9 CO Aaron Cowen b X1 0.00 3434967.00 0.00 3434967.00 3434967.00 N 1.1 HC IN Erasca, Inc. 3115 Merryfield Row, Suite 300, San Diego, CA 92121 Suvretta Capital Management, LLC Averill Master Fund, Ltd. Aaron Cowen Suvretta Capital Management, LLC 540 Madison Avenue, 7th Floor New York, New York 10022 United States of America Averill Master Fund, Ltd. c/o Maples Corporate Services Limited P.O. Box 309 Ugland House Grand Cayman KY1-1104 Cayman Islands Aaron Cowen c/o Suvretta Capital Management, LLC 540 Madison Avenue, 7th Floor New York, New York 10022 Suvretta Capital Management, LLC - Delaware Averill Master Fund, Ltd. - Cayman Islands Aaron Cowen - United States N IA Suvretta Capital Management, LLC - 3,434,967 Averill Master Fund, Ltd. - 2,945,497 Aaron Cowen - 3,434,967 Suvretta Capital Management, LLC - 1.1% Averill Master Fund, Ltd. - 0.9% Aaron Cowen - 1.1% Suvretta Capital Management, LLC - 0 Averill Master Fund, Ltd. - 0 Aaron Cowen - 0 Suvretta Capital Management, LLC - 3,434,967 Averill Master Fund, Ltd. - 2,945,497 Aaron Cowen - 3,434,967 Suvretta Capital Management, LLC - 0 Averill Master Fund, Ltd. - 0 Aaron Cowen - 0 Suvretta Capital Management, LLC - 3,434,967 Averill Master Fund, Ltd. - 2,945,497 Aaron Cowen - 3,434,967 N Y N All of the securities reported in this Schedule 13G Amendment No. 1 are directly owned by advisory clients of Suvretta Capital Management, LLC. None of those advisory clients may be deemed to beneficially own more than 5% of the Common Stock, $0.0001 par value per share. N Please see Exhibit B attached hereto. Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Exhibit A - Joint Filing Agreement Exhibit B - Control Person Identification Suvretta Capital Management, LLC /s/ Andrew Nathanson Andrew Nathanson, General Counsel and Chief Compliance Officer 05/12/2026 Averill Master Fund, Ltd. /s/ Andrew Nathanson Andrew Nathanson, Authorized Signatory 05/12/2026 Aaron Cowen /s/ Aaron Cowen Aaron Cowen 05/12/2026 * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class. EX-99 2 d12155426_ex99-a.htm

 

Exhibit A

JOINT FILING AGREEMENT

The undersigned agree that this Schedule 13G Amendment No. 1 dated May 12, 2026 relating to the Common Stock, $0.0001 par value per share, of Erasca, Inc. shall be filed on behalf of the undersigned.

 

SUVRETTA CAPITAL MANAGEMENT, LLC

 

By: /s/ Andrew Nathanson

  Name: Andrew Nathanson
  Title:   General Counsel and Chief Compliance Officer

 

 

 

AVERILL MASTER FUND, LTD.

 

By: /s/ Andrew Nathanson

  Name: Andrew Nathanson
  Title:   Authorized Signatory

 

 

 

AARON COWEN

 

By: /s/ Aaron Cowen

 

 

 

 EX-99 3 d12155426_ex99-b.htm

 

 

Exhibit B

CONTROL PERSON IDENTIFICATION

Suvretta Capital Management, LLC is the relevant entity for which Aaron Cowen is the control person.

SK 27504 0001 12155426 v1